Vu1 (VUOC) 10-K 31 Mar 14 2013 FY Annual report Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 20, 2014	Jun. 30, 2013
Document and Entity Information	'	'	'
Entity Registrant Name	'Vu1 CORP	'	'
Entity Central Index Key	'0000906448	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	10,701,097	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Fiscal Period Focus	'FY	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Public Float	'	'	$8,744,853

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets	'	'
Cash	$92,795	$328,188
Prepaid expenses	190,005	42,722
Total current assets	282,800	370,910
Non-current assets	'	'
Equipment, net of accumulated depreciation of $3,402 and $0	30,614	'
Loan costs	'	118,500
Total assets	313,414	489,410
Current liabilities	'	'
Accounts payable	1,148,368	956,558
Accrued payroll	192,725	192,725
Accrued interest	324,531	52,134
Loan payable	100,000	100,000
Convertible debentures, net of discount of $0 and $571,254, respectively	3,905,975	3,546,496
Convertible bridge loans	'	309,000
Liabilities of Sendio	555,454	555,454
Total current liabilities	6,227,053	5,712,367
Total liabilities	6,227,053	5,712,367
Vu1 Corporation's stockholders' deficit	'	'
Preferred stock, $1.00 par value; 10,000,000 shares authorized; no shares issued and outstanding	'	'
Common stock, no par value; 90,000,000 shares authorized; 10,576,097 and 7,130,226 shares issued and outstanding, respectively	82,609,032	78,279,737
Accumulated deficit	-88,426,616	-83,406,639
Total Vu1 Corporation's stockholders' deficit	-5,817,584	-5,126,902
Non-controlling interest	-96,055	-96,055
Total stockholders' deficit	-5,913,639	-5,222,957
Total liabilities and stockholders' deficit	$313,414	$489,410

CONSOLIDATED_BALANCE_SHEETS_PA

CONSOLIDATED BALANCE SHEETS PARENTHETICAL (USD $)	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED BALANCE SHEETS PARENTHETICAL	'	'
Accumulated depreciation	$3,402	'
Discount associated with convertible debentures, current	'	$571,254
Preferred stock par value	$1	$1
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	'	'
Preferred stock shares outstanding	'	'
Common stock par value	'	'
Common stock shares authorized	90,000,000	90,000,000
Common stock shares issued	10,576,097	7,130,226
Common stock shares outstanding	10,576,097	7,130,226

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Operating expenses	'	'
Research and development	$646,611	$547,276
General and administrative	1,692,010	1,538,312
Marketing	374,806	755,307
Total operating expenses	2,713,427	2,840,895
Loss from operations	-2,713,427	-2,840,895
Other income (expense)	'	'
Interest income	'	19
Interest expense	-1,191,786	-1,309,917
Loss on conversion of debt	-1,114,764	-353,161
Loss on extinguishment of accounts payable	'	-63,473
Derivative valuation gain	'	592,783
Gain on disposal of foreign subsidiary	'	149,196
Total other income (expense)	-2,306,550	-984,553
Loss before provision for income taxes	-5,019,977	-3,825,448
Provision for income taxes	'	'
Net loss	-5,019,977	-3,825,448
Foreign currency translation adjustments	'	25,374
Reclassification adjustment on disposal of foreign subsidiary	'	-149,196
Comprehensive loss	($5,019,977)	($3,949,270)
Loss per share	'	'
Loss per share - Basic	($0.55)	($0.64)
Loss per share - Diluted	($0.55)	($0.64)
Weighted average shares outstanding	'	'
Weighted average shares outstanding - Basic	9,144,940	5,949,211
Weighted average shares outstanding - Diluted	9,144,940	5,949,211

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Common Stock	Accumulated Deficit	Accumulated Other Comprehensive Income	Non-Controlling Interest	Total
Balance at Dec. 31, 2011	$74,898,008	($79,581,191)	$123,822	($96,055)	($4,655,416)
Balance - Shares at Dec. 31, 2011	5,568,253	'	'	'	'
Share-based compensation - options	134,349	'	'	'	134,349
Share-based compensation - stock	311,336	'	'	'	311,336
Share-based compensation - stock - Shares	168,500	'	'	'	'
Issuance of units of stock and warrants for cash	1,825,768	'	'	'	1,825,768
Issuance of units of stock and warrants for cash - Shares	932,365	'	'	'	'
Issuance of stock and warrants for services	143,954	'	'	'	143,954
Issuance of stock and warrants for services - Shares	79,585	'	'	'	'
Issuance of stock and warrants for bridge note payable	546,593	'	'	'	546,593
Issuance of stock and warrants for bridge note payable - Shares	55,267	'	'	'	'
Issuance of stock and warrants for accounts payable	374,750	'	'	'	374,750
Issuance of stock and warrants for accounts payable - Shares	262,000	'	'	'	'
Issuance of stock for accounts payable	44,979	'	'	'	44,979
Issuance of stock for accounts payable - Shares	64,256	'	'	'	'
Net loss	'	-3,825,448	'	'	-3,825,448
Foreign currency translation adjustments	'	'	25,374	'	25,374
Reclassification adjustment on disposal of foreign subsidiary	'	'	-149,196	'	-149,196
Balance at Dec. 31, 2012	78,279,737	-83,406,639	'	-96,055	-5,222,957
Balance - Shares at Dec. 31, 2012	7,130,226	'	'	'	'
Share-based compensation - options	478,228	'	'	'	478,228
Share-based compensation - stock	631,139	'	'	'	631,139
Share-based compensation - stock - Shares	454,216	'	'	'	'
Issuance of units of stock and warrants for cash	1,503,465	'	'	'	1,503,465
Issuance of units of stock and warrants for cash - Shares	1,262,334	'	'	'	'
Issuance of stock and warrants for bridge note payable	1,453,905	'	'	'	1,453,905
Issuance of stock and warrants for bridge note payable - Shares	368,161	'	'	'	'
Issuance of stock and warrants for conversion of ST Debt	139,020	'	'	'	139,020
Issuance of stock and warrants for conversion of ST Debt - Shares	73,333	'	'	'	'
Issuance of stock and warrants for conversion of debenture	123,538	'	'	'	123,538
Issuance of stock and warrants for conversion of debenture - Shares	101,260	'	'	'	'
Amendment of Unit Offering - Shares	1,186,567	'	'	'	'
Net loss	'	-5,019,977	'	'	-5,019,977
Reclassification adjustment on disposal of foreign subsidiary	'	'	'	'	-149,146
Balance at Dec. 31, 2013	$82,609,032	($88,426,616)	'	($96,055)	($5,913,639)
Balance - Shares at Dec. 31, 2013	10,576,097	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows From Operating Activities	'	'
Net loss	($5,019,977)	($3,825,448)
Adjustments to reconcile net loss to net cash flows from operating activities:	'	'
Depreciation	3,402	1,740
Share-based compensation	1,109,367	589,639
Amortization of discount on long-term convertible notes	571,254	1,031,098
Amortization of loan costs	118,500	223,230
Amortization of prepaid interest	25,000	1,486
Derivative valuation gain	'	-592,783
Loss on extinguishment of debt	1,114,764	353,160
Loss on extinguishment of accounts payable	'	63,473
Gain on disposal of foreign subsidiary	'	-149,196
Changes in assets and liabilities:	'	'
Change in accounts receivable	'	3,616
Change in prepaid expenses	-172,283	9,083
Change in accounts payable	260,971	631,223
Change in accrued payroll	'	90,898
Change in accrued interest	272,396	'
Net cash flows from operating activities	-1,716,606	-1,568,781
Cash flows from investing activities:	'	'
Purchase of equipment	-34,015	'
Net cash flows from investing activities	-34,015	'
Cash flows from financing activities:	'	'
Net proceeds from sales of common stock and warrants	1,503,465	1,825,768
Payment on convertible debenture	-88,237	'
Proceeds from loan payable	100,000	100,000
Cash paid for loan costs and prepaid interest	'	-40,000
Net cash flows from financing activities	1,515,228	1,885,768
Effect of exchange rate changes on cash	'	209
Net change in cash	-235,393	317,196
Cash, beginning of period	328,188	10,992
Cash, end of period	92,795	328,188
Supplemental Cash Flow Information:	'	'
Cash paid for interest	'	'
Supplemental Noncash Investing and Financing Activities:	'	'
Conversion of bridge loan and interest to stock and warrants	1,453,905	193,431
Conversion of debenture for stock	123,538	'
Issuance of common stock and warrants for note payable and interest	110,000	'
Issuance of Common Stock and Warrants for Accounts Payable	'	$356,256

Note_1_Business_and_Organizati

Note 1 - Business and Organization	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 1 - Business and Organization	'
	NOTE 1 - BUSINESS AND ORGANIZATION
	General
	All references in these consolidated financial statements to “we,” “us,” “our,” and the “Company” are to Vu1 Corporation, Sendio, s.r.o., our former Czech Republic based subsidiary, and our inactive subsidiary Telisar Corporation, unless otherwise noted or indicated by its context.
	We are focused on designing, developing and selling a line of mercury free, energy efficient lighting products based on our proprietary light-emitting technology. For the past several years, we have primarily focused on research and development efforts for our technology and the related manufacturing processes.
	In September 2007, we formed Sendio, s.r.o. (“Sendio”) in the Czech Republic as a wholly-owned subsidiary for the purpose of operating a research and development and manufacturing facility.  As discussed in Note 13, the Company ceased the operations of Sendio and filed a petition of insolvency effective on February 13, 2012.
	We have one inactive subsidiary, Telisar Corporation, a California corporation and 66.67% majority-owned subsidiary.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 2 - Summary of Significant Accounting Policies	'
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation
	The consolidated financial statements include the accounts of Vu1 and all of its wholly-owned and controlled subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
	Translating Financial Statements
	The functional currency of Sendio was the Czech Koruna (CZK).  The accounts of Sendio contained in the accompanying consolidated balance sheets as of December 31, 2013 and 2012 have been translated into United States dollars at the exchange rate prevailing as of those dates. Translation adjustments were included in “Accumulated Other Comprehensive Income,” a separate component of stockholders’ equity. During the year ended December 31, 2012 we recognized the balance of Accumulated Other Comprehensive Income of $149,146 as a gain on liquidation of foreign subsidiary in the accompanying statement of operations for the year ended December 31, 2012 as we no longer have an ongoing investment in a foreign subsidiary.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	For purposes of the statements of cash flows, we consider all investments purchased with original maturities of three months or less to be cash equivalents. At December 31, 2013 we have no cash in excess of federal insurance limits.
	Equipment
	Equipment is comprised of equipment used in the testing and development of the manufacturing process for our lighting products and is stated at cost. We provide for depreciation using the straight-line method over the estimated useful lives of three to five years. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains or losses on the sale of equipment are reflected in the statements of operations.
	Income Taxes
	We recognize the amount of income taxes payable or refundable for the current year and recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement amounts of certain assets and liabilities and their respective tax bases. Deferred tax assets and deferred tax liabilities are measured using enacted tax rates expected to apply to taxable income in the years those temporary differences are expected to be recovered or settled. A valuation allowance is required when it is less likely than not that we will be able to realize all or a portion of our deferred tax assets.
	FASB ASC 740-10-25 clarifies the accounting for uncertain tax positions and requires that an entity recognizes in the consolidated financial statements the impact of a tax position, if that position is more likely than not of being sustained upon examination, based on the technical merits of the position.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits, if and when required, as part of income tax expense in the consolidated statements of operations.
	Loan Costs
	Loan costs are amortized to interest expense using the straight line method, which approximates the effective interest method, over the life of the related loans.
	Long-Lived Assets
	Long-lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount that the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  Management reviewed the assets at December 31, 2013 and determined there was no impairment.
	Fair Value of Financial Instruments
	Financial instruments consist of cash, payables and accrued liabilities, loans payable, bridge loans and convertible debentures. The fair value of our cash, receivables, payables and accrued liabilities and loans payable are carried at historical cost; their respective estimated fair values approximate their carrying values due to the short term nature of these items. It is not practical to determine the fair value of our convertible debentures due to the unique terms and embedded financial instruments.
	Derivative financial instruments, as defined in ASC 815 “Accounting for Derivative Financial Instruments and Hedging Activities” consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g., interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. We generally do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.
	Fair Value Measurements
	ASC 820 “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Significant fair value measurements resulted from the application of ASC 815 to our convertible promissory note and warrant financing arrangements and ASC 718-10 for our share-based payment arrangements.
	Non-Controlling Interest
	Non-controlling interest represents the equity of the 33.3% non-controlling shareholders of Telisar Corporation.  The subsidiary had no operations during 2013 and 2012.
	Revenue Recognition
	Revenues are recognized when (a) persuasive evidence of an arrangement exists, (b) delivery has occurred and no significant obligations remain, (c) the fee is fixed or determinable and (d) collection is determined to be probable.
	Research and Development Costs
	For financial reporting purposes, all costs of research and development activities performed internally or on a contract basis are expensed as incurred. For the years ended December 31, 2013 and 2012, research and development expenses were comprised primarily of technical consulting expenses, salaries and related benefits and overheads, travel, rent and operational costs related to the development of the production line.
	Share-Based Payments
	We account for share-based compensation expense to reflect the fair value of share-based awards measured at the grant date.  This expense is recognized over the requisite service period and is adjusted each period for anticipated forfeitures. We estimate the fair value of each share-based award on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield. On October 26, 2007 our Board of Directors approved the Vu1 Corporation 2007 Stock Incentive Plan (the “Stock Incentive Plan”).  A total of 500,000 shares of our common stock were authorized for issuance under the Stock Incentive Plan.  The Stock Incentive Plan was approved by our stockholders on May 22, 2008. On March 14, 2011, our Board of Directors increased the number of shares of our common stock that we are authorized to issue under our Stock Incentive Plan from 500,000 shares to 1,000,000 shares.  A majority of our stockholders approved the amendment to the Stock Incentive Plan on October 10, 2011. On August 26, 2013 the board of directors increased the number of shares authorized for issuance under the 2007 Stock Incentive Plan by 1,500,000 shares to a total of 2,500,000 shares. See Note 10.
	Comprehensive Income
	Comprehensive income includes all changes in equity (net assets) during a period from non-owner sources. Other comprehensive income presented in the accompanying consolidated financial statements consists of foreign currency translation adjustments and a reclassification on disposal of foreign subsidiary.
	Loss Per Share
	We calculate basic loss per share by dividing loss available to common stockholders by the weighted-average number of shares of common stock outstanding, excluding unvested stock. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common shares, including unvested stock, had been issued and if the additional common shares were dilutive.
	The following potentially dilutive common shares are excluded from the computation of diluted net loss per share for all periods presented because the effect is anti-dilutive due to our net losses:
		Year ended December 31,
		2013	2012
	Warrants	4,772,228	2,012,034
	Convertible debt	1,152,223	374,346
	Stock options	595,088	309,004
	Unvested stock	319,231	168,500
	Total potentially dilutive securities	6,838,770	2,863,884
	Recently Announced Accounting Standards – In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). This update requires companies to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, unless certain conditions exist. ASU 2013-11 became effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted. The Company will adopt ASU 2013-11 when required in the first quarter of 2014. The Company does not believe the impact of ASU 2013-11 will have a material effect on the Company’s consolidated financial statements or on its financial condition.
	ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment, permits, but does not require, an entity to conduct an initial qualitative assessment to determine whether it is more likely than not that a non-goodwill indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test currently required (i.e., comparing the asset's fair value with its carrying amount). This new standard was adopted by the Company on September 30, 2012 and had no significant effect on the accompanying consolidated financial statements.
	ASU 2011-11, Disclosures about Offsetting Assets and Liabilities, requires disclosures about assets and liabilities that are offset or have the potential to be offset. This new guidance was effective for reporting periods beginning January 1, 2013, with retrospective application required. The adoption of this guidance did not have a material impact on the Company’s results of operations, financial position or disclosures.

Note_3_Going_Concern_Matters

Note 3 - Going Concern Matters	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 3 - Going Concern Matters	'
	NOTE 3 - GOING CONCERN MATTERS
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States which contemplate our continuation as a going concern. For the year ended December 31, 2013, we had a net loss of $5,019,977 and we had negative cash flows from operations of $1,716,606. In addition, we had an accumulated deficit of $88,426,616 at December 31, 2013. These factors raise substantial doubt about our ability to continue as a going concern.
	Recovery of our assets is dependent upon future events, the outcome of which is indeterminable. Our attainment of profitable operations is dependent upon obtaining adequate financing and achieving a level of sales adequate to support our cost structure. In addition, realization of a significant portion of the assets in the accompanying balance sheet is dependent upon our ability to meet our financing requirements and the success of our plans to sell our product. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.
	Subsequent to year end, we raised gross proceeds of $150,000 in a private placement of our common stock and warrants to accredited investors.  See Note 14.

Note_4_Related_Party_Transacti

Note 4 - Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 4 - Related Party Transactions	'
	NOTE 4 - RELATED PARTY TRANSACTIONS
	During the year ended December 31, 2013 we issued 48,842 shares of common stock with a fair value of $75,000 to SAM Advisors, LLC. The issuances were based on the closing market prices as of the date of issuance pursuant to our agreement to convert their $12,500 monthly consulting fee to stock at the closing market price on the last business day of each month. SAM Advisors, Inc. is an entity controlled by William B. Smith, our chairman and chief executive officer.
	During the year ended December 31, 2013 we issued 6,143 shares of common stock with a fair value of $11,250 to Charles Hunt, a member of our board of directors. The issuances were based in the closing market prices as of the date of issuance pursuant to our agreement to convert $3,750 of his monthly consulting fee to stock at the closing market price on the last business day of each month.
	During the year ended December 31, 2012 we paid consulting fees of $125,000 to SAM Advisors, LLC for services rendered to the Company. In addition, From August 31, 2012 to December 31, 2012 we issued 56,208 shares of common stock with a fair value of $62,500 to SAM Advisors, LLC pursuant to our agreement with SAM to convert their monthly fee to common stock at the price of our common stock on the last day of each month.  SAM Advisors LLC is owned by William B. Smith, our Chairman and chief executive officer.
	During the year ended December 31, 2012, two of our board members invested $105,000 and $15,000 in our unit private placement as discussed in Note 10.
	During the year ended December 31, 2012, one of our board members converted a loan totaling $57,385 (including $7,385 of accrued interest and loan fees) into 16,396 shares of our common stock, three year warrants to purchase 16,396 shares of our common stock at an exercise price of $3.75 per share and three year warrants to purchase 16,429 shares of our common stock at an exercise price of $11.00 per share as discussed in Note 7.
	During the year ended December 31, 2012 we paid fees of $22,382 to Duncan Troy for services rendered as the managing director of Sendio.  Mr. Troy is a member of our board of directors.

Note_5_Commitments_and_Conting

Note 5 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 5 - Commitments and Contingencies	'
	NOTE 5 - COMMITMENTS AND CONTINGENCIES
	Operating Leases
	On December 18, 2012 we entered into a 6 month lease for office space in New York, New York. This lease was extended to December 31, 2013 on the same terms. Monthly rental payments are $2,035.  The lease was terminated by its terms as of that date.
	On July 11, 2011 we entered into a month to month lease agreement for office space in New Hampshire.  Monthly rental payments were $1,445 under the lease.  This lease was terminated in April, 2012.
	Total rent expense was $24,647 and $9,859 for the years ended December 31, 2013 and 2012, respectively.
	Subsequent to December 31, 2013 the Company entered into a lease for a research and development facility in the United States.  See Note 14.
	Investment Banking Agreements
	On June 7, 2011, we entered into an agreement with Rodman & Renshaw, LLC to act as our exclusive placement agent for the sale of securities on June 22, 2011.  The agreement specified cash compensation of 7% of the purchase price paid in an offering plus warrants equal to 7% of common shares issued or issuable under the offering on the same terms as offered to investors in the private placement.  In addition, cash compensation of 7% of any proceeds from the exercise of warrants issued in conjunction with a private placement will be paid.  The agreement terminated on July 21, 2011. The contingent obligation for fees and warrants terminated on January 21, 2013.
	On January 24, 2011, we entered into an agreement with Rodman & Renshaw, LLC to act as our exclusive placement agent for the sale of securities on February 8, 2011.  The agreement specified cash compensation of 7% of the purchase price paid in an offering plus warrants equal to 7% of common shares issued or issuable under the offering on the same terms as offered to investors in the private placement.  In addition, cash compensation of 7% of any proceeds from the exercise of warrants issued in conjunction with a private placement will be paid.  The agreement terminated 30 days after a successful private placement.  The contingent obligation for fees and warrants terminated in 2012.

Note_6_Convertible_Debentures

Note 6 - Convertible Debentures	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 6 - Convertible Debentures	'
	NOTE 6 – CONVERTIBLE DEBENTURES
	On June 22, 2011, pursuant to a Securities Purchase Agreement, dated as of June 16, 2011, with several institutional investors, we completed a private placement of our original issue discount convertible debentures (referred to as the convertible debentures), receiving gross proceeds of $3,500,000.  Each convertible debenture was issued at a price equal to 85% of its principal amount.  The convertible debentures matured on June 22, 2013, two years after the date of their issuance and did not bear regularly scheduled interest.  Investors may convert their convertible debentures into shares of our common stock at any time and from time to time on or before the maturity date, at a conversion price of $11.00 per share.
	The convertible debentures will mandatorily convert at our option into shares of our common stock at the conversion price, if the closing bid price for the common stock exceeds $30.00 per share for a period of 10 consecutive trading days, provided that such underlying shares have been fully registered for resale with the U.S. Securities and Exchange Commission (SEC).
	The convertible debentures are unsecured, general obligations of our company, and rank pari passu with our other unsecured and unsubordinated liabilities.  The convertible debentures are not redeemable or subject to voluntary prepayment by us prior to maturity.  The convertible debentures were identical for all of the investors except for principal amount.
	The investors agreed not to convert their convertible debentures or exercise their warrants, and we will not be permitted to require a mandatory conversion, to the extent such conversion, exercise or issuance would result in beneficial ownership of more than 4.99% of our outstanding shares at such time.
	Events of default under the convertible debentures include:
	•              failure to pay principal or any liquidated damages on any convertible debenture when due;
	•              failure to perform other covenants under the convertible debentures that is not cured five trading days after notice by holders;
	•              default under the other financing documents, subject to any grace or cure period provided in the applicable agreement, document or instrument;
	•              certain events of bankruptcy or insolvency of our company or any significant subsidiary.  The lender has waived this event of default with respect to the insolvency of Sendio.
	•              any default by our company or any subsidiary under any instrument in excess of $150,000 that results in such obligation becoming due and payable prior to maturity;
	•              we become party to a change of control transaction, or dispose of greater than 50% of our assets; and
	•              failure to deliver common stock certificates to a holder prior to the tenth trading day after a convertible debenture conversion date.
	Upon an event of default, the outstanding principal amount of the convertible debentures, plus a default premium, shall become immediately due and payable to the holders of the convertible debentures.
	The convertible debentures contain various covenants that limit our ability to:
	•              incur additional indebtedness, other than permitted indebtedness as defined in the convertible debenture;
	•              incur specified liens, other than permitted liens as defined in the convertible debenture;
	•              amend our certificate of incorporation or by-laws in a material adverse manner to the holders; and
	•              repay or repurchase more than a de minimus number of shares of our common stock.
	As part of the financing, we also agreed not to undertake a reverse or forward stock split or reclassification of our common stock until the one-year anniversary of the closing date, except with the consent of a majority in interest of the holders or in connection with an up-listing of our common stock onto a trading market other than the OTC Bulletin Board.
	We also issued to the investors five-year warrants to purchase up to 187,175 shares of our common stock at an exercise price of $13.00 per share.  The warrants may be exercised on a cashless basis at any time after the earlier of (i) one year after the date of their issuance or (ii) the completion of the applicable holding period required by Rule 144 in the event the underlying shares have not been fully registered for resale with the SEC.  The warrants are not callable.  Neither the warrants nor the convertible debentures contain a provision for anti-dilution adjustments in the event of a subsequent equity financing at a price less than the respective warrant exercise price or convertible debenture conversion price.
	Pursuant to a Registration Rights Agreement, dated as of June 16, 2011, with the investors, we agreed to file a shelf registration statement covering the resale of the shares of common stock issuable upon the conversion of the convertible debentures and exercise of the warrants within 30 days after the closing, use our best efforts to cause the shelf registration statement to be declared effective within 90 days after the closing (or 120 days in the event of a “full review” by the SEC), and keep the shelf registration statement effective until the underlying shares have been sold or may be sold without volume or manner of sale restrictions pursuant to Rule 144 under the Securities Act of 1933 and if we are unable to comply with this covenant, we will be required to pay liquidated damages to the investors in the amount of 1.5% of the investors’ purchase price per month during such non-compliance (capped at a maximum of 10% of the purchase price), with such liquidated damages payable in cash.  We filed the registration statement on July 15, 2011 and it was declared effective on July 26, 2011.  We evaluated any liability under the registration rights agreement at December 31, 2013 and determined no accrual was necessary.
	Effective June 22, 2013, the Company entered into a letter agreement with holders of $2,553,000 in principal amount of the Debentures.  The maturity date of these Debentures was extended to June 23, 2014 and the conversion price was reduced from $11.00 to $2.50 per share.  In addition, these Debentures will bear interest at an annual rate of 10% per annum, payable in equal installments on the six month and one year anniversary of the letter agreement.
	Also, effective June 22, 2013, the Company entered into a separate letter agreement with the holder of approximately $123,538 in principal amount of the Debentures to reduce the conversion price of these Debentures from $11.00 to $1.22 per share.  This holder then converted the principal amount of their Debentures into 101,260 shares of common stock.
	We evaluated the amended debentures above to determine if there was an extinguishment of debt or beneficial conversion feature arising as a result of the amendments and determined there was none.
	On June 22, 2013, the Company did not make the required payment on the remaining $1,441,213 in principal amount of the Debentures described above, which constitutes an event of default under the terms of the remaining original Debentures.  As a result, the Company recorded a penalty of 10% of the principal amount of $144,121 as interest expense on the accompanying statement of operations for the year ended December 31, 2013. The Company is also liable for all other amounts, costs, expenses and liquidated damages due in respect of those Debentures.  Additionally, the remaining original Debentures will bear default interest at a rate of 18% per annum. As a result of the Debentures being past due, the investors may at any time exercise their remedies under the terms of the Debentures.
	The carrying value at December 31, 2013 and 2012 of the convertible debentures is as follows:
		31-Dec-13	31-Dec-12
	Debentures Due June 22, 2013, in default at December 31, 2013, interest at 18%	$                      1,352,975	$                   4,117,750
	Debentures Due June 23, 2014, interest at 10%	2,553,000	-
	Original issue discount	-	(155,443)
		3,905,975	3,962,307
	Beneficial conversion feature and warrant allocation	-	(415,811)
	Carrying value	$                      3,905,975	$                   3,546,496
	The original issue discount of the convertible debentures was amortized over their two-year life using the effective interest method.
	The proceeds were first allocated between the convertible debentures and the warrants based upon their relative fair values. The estimated fair value of the warrants issued with the convertible debentures of $1,018,582 was calculated using the Black-Scholes option pricing model and the following assumptions: market price of common stock – $9.00 per share; estimated volatility – 84.6%; risk-free interest rate – 1.58%, expected dividend rate – 0% and expected life – 5.0 years. This resulted in allocating $788,972 to the warrants and $2,711,028 to the convertible debentures.
	Next, the intrinsic value of the beneficial conversion feature was computed as the difference between the fair value of the common stock issuable upon conversion of the convertible debentures and the total price to convert based on the effective conversion price. This resulted in allocating $658,840 to the beneficial conversion feature. The resulting $1,447,812 discount to the convertible debentures is being amortized over the two-year term of the convertible debentures using the effective interest method.
	In conjunction with the placement of the convertible debentures, we paid our investment banker $245,000 as a placement fee and issued five-year warrants to purchase 26,205 shares of our common stock at an exercise price of $13.00 per share.  All terms are identical to the warrants issued to the holders of the convertible debentures. The estimated fair value of the warrants issued with the convertible debentures of $142,601 was calculated using the Black-Scholes option pricing model and the following assumptions: market price of common stock – $9.00 per share; estimated volatility – 84.6%; risk-free interest rate – 1.58%, expected dividend rate – 0% and expected life – 5.0 years.  In addition, we incurred legal and other costs of $53,500 paid in cash.  These costs, totaling $441,101 were recorded as loan costs on the accompanying balance sheet on the date of issuance and were amortized to interest expense using the straight line method, which approximates the effective interest method, over the two-year term of the convertible debentures.
	Interest expense related to the convertible debentures is as follows:
		Year ended December 31,
		2013	2012
	Amortization of original issue discount	$                         155,443	$                      309,628
	Amortization of beneficial conversion feature and warrant allocation	415,811	722,956
	Amortization of loan costs	104,392	220,852
	Penalty interest payable in cash	144,121	-
	Stated interest payable in cash	259,168	-
		$                      1,078,935	$                    1,253,436

Note_7_Convertible_Bridge_Loan

Note 7 - Convertible Bridge Loans	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 7 - Convertible Bridge Loans	'
	NOTE 7 – CONVERTIBLE BRIDGE LOANS
	In October and November 2011, we received $475,000 in gross proceeds from six existing stockholders in an interim bridge loan financing involving the issuance of 12% convertible promissory notes and warrants to purchase common stock.  Included in the proceeds was $50,000 received from Mark W. Weber, a member of our board of directors.  Under the notes, the loans are due upon the earlier of (a) the closing of financing pursuant to which shares of common stock or other equity securities are issued by us for aggregate consideration of not less than $5,000,000, through the (i) conversion of the note, including accrued interest, or (ii) at the lender’s option, repayment of the note, or (b) in any event, two years after the issuance of the note.  The number of shares of common stock issuable upon conversion of the note will be based on a conversion price equal to a 15% discount to the price obtained in any round of equity financing.  In the event we fail to repay the promissory notes on or before November 30, 2011, the note’s interest rate will be increased to 15% per annum.  We did not pay the promissory notes prior to that date, and the interest rate was increased to 15% per annum.
	Total interest expense for the year ending December 31, 2013 and 2012 was $7,027 and $54,103 (including $14,250 of loan costs in 2012), respectively.
	In addition to interest on the promissory note, each note holder received a warrant to purchase the number of shares of common stock determined by dividing 115% of the principal amount of the note by the price at which our common stock is sold in any round of equity financing not less than $5,000,000, times 100%.  The warrants will be exercisable at any time, commencing 90 days after the closing of the round of financing, and from time to time for a period of three years after the issuance date, at an exercise price of $11.00 per share (subject to appropriate adjustment in the event of any subsequent stock split or similar transaction).
	During February, 2013 three of the convertible bridge loans totaling $368,162 (including accrued interest and loan fees of $68,162) were converted into 368,162 shares of our restricted common stock, three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share and three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share.  The fair value of the common stock was $662,690 based on the market prices of our common stock on the date of conversion of $1.80 per share.  The fair value of the three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share was $633,121 and fair value of the three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share was $158,094.  We recognized a loss on debt conversion for the year ended December 31, 2013 in the amount of $1,085,744.
	The fair value of the warrants issued upon the conversions in 2013 was computed using the Black Scholes Option Pricing model using the following assumptions – expected life –3 years, risk free interest rate – 0.82%, volatility – 227.1%, and an expected dividend rate of 0%.
	During the year ended December 31, 2012, three of the convertible bridge loans totaling $193,431 (including accrued interest and loan fees of $18,431) were converted into 55,267 units in our private placement offering as discussed in Note 10.  Accordingly, we issued 55,267 shares of our common stock, three year warrants to purchase 55,267 shares of our common stock at an exercise price of $3.75 per share and three year warrants to purchase 57,500 shares of our common stock at an exercise price of $11.00 per share.  The fair value of the common stock was $230,540 based on the market prices of our common stock on the respective dates of conversion ranging from $2.11 to $5.75 per share.  The fair value of the three year warrants to purchase 55,267 shares of our common stock at an exercise price of $3.75 per share was $171,023 and fair value of the three year warrants to purchase 57,500 shares of our common stock at an exercise price of $11.00 per share was $145,029.  We recognized a loss on debt conversion in the amount of $353,161 on the dates of conversion for the notes.
	The fair value of the warrants issued upon the conversions in 2012 was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.31% to 0.82%, volatility – 103.6% to 198.4%, and an expected dividend rate of 0%.
	One of the convertible bridge loans converted in 2012 was held by Mark Weber, a member of our board of directors, who converted a loan totaling $57,385 (including $7,385 of accrued interest and loan fees) into 16,396 shares of our common stock, three year warrants to purchase 16,396 shares of our common stock at an exercise price of $3.75 per share and three year warrants to purchase 16,429 shares of our common stock at an exercise price of $11.00 per share.

Note_8_Loans_Payable

Note 8 - Loans Payable	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 8 - Loans Payable	'
	NOTE 8 – LOANS PAYABLE
	On December 20, 2012, we received gross proceeds of $100,000 pursuant to the terms of a Loan Agreement dated December 20, 2012.  The loan is secured by a deed of assignment for certain future inventory and proceeds from the sale of that inventory as described in the deed of assignment.  The loan was payable on June 23, 2013, six months from the date of the agreement.  We prepaid interest of $25,000 for the term of the loan and $15,000 for loan costs, which were amortized over the life of the note.  We recognized $81,714 and $1,486 of interest expense and $23,514 and $892 for loan cost amortization within interest expense for the years ended December 31, 2013 and 2012, respectively.
	On June 23, 2013 we did not repay the loan and it is in default.  As a result of the default, the interest rate on the loan is 109.5% per annum from the date of default.
	Total principal payments for future years for the Convertible Bridge Loans, the Convertible Debentures described in Note 7, the Convertible Bridge Loans described in Note 7 and the Loan Payable are as follows as of December 31, 2013:
		31-Dec-13
	2014	4,005,975
		$    4,005,975
	On May 16, 2013 we received gross proceeds of $100,000 pursuant to a Loan Agreement as of that date.  The term of the loan was for 30 days.  Total interest for the 30 day term was $10,000, which was recognized as interest expense for the year ended December 31, 2013.  On June 18, 2013 the holder of the loan converted $110,000 of principal and interest in our unit private placement as further described in Note 10 at a conversion price of $1.50 per share into 73,333 shares of common stock and three-year warrants to purchase common stock at an exercise price of $2.00 per share.  The fair value of the common stock was $95,333 based on the market prices of our common stock on the date of conversion of $1.30 per share.  The fair value of the three year warrants to purchase 73,333 shares of our common stock at an exercise price of $2.00 per share was $43,687. We recognized a loss on conversion of debt for the year ended December 31, 2013 in the amount of $29,020.
	The fair value of the warrants issued upon the conversion was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.42%, volatility – 91.4%, and an expected dividend rate of 0%.

Note_9_Derivative_Financial_In

Note 9 - Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 9 - Derivative Financial Instruments	'
	NOTE 9 – DERIVATIVE FINANCIAL INSTRUMENTS
	Derivative financial instruments were classified as liabilities and carried at fair value, with changes reflected in the statement of operations.
	On February 9, 2011, we issued five-year warrants to purchase 262,750 shares of our common stock at an exercise price of $12.00 per share in conjunction with a private placement.  If we issued common stock or common stock equivalents at a price per share less than the exercise price of the warrants, the exercise price of the warrants was decreased to equal the price at which the common stock or common stock equivalents were issued.  The exercise price could not be reduced below $9.00 per share. On June 22, 2011, the exercise price of the warrants was reduced from $12.00 per share to $11.00 per share as a result of the issuance of the convertible debentures at a conversion price of $11.00 per share as described in Note 6.
	On January 24, 2012, the exercise price of the warrants was further reduced to $9.00 per share in conjunction with the 2012 Unit Offering as described in Note 10.  As a result, we recognized the difference in the fair value of the warrants of $46,444 as of that date as an additional unrealized fair value change in the derivative gain for the year ended December 31, 2012.  As a result of this reduction, the exercise price no longer has the potential for further adjustment, and we determined that the warrants no longer represented a derivative liability, and the remaining balance of the derivative liability was recognized as a derivative gain in the amount of $639,227 for the year ended December 31, 2012.
	The Company used the Black-Scholes option valuation model to measure the fair value of the warrants, and based on the following assumptions: market value of common stock of $4.15, expected life of 4.04 years, volatility of 81.0% and risk free interest rate of 0.66%.

Note_10_Stockholders_Equity

Note 10 - Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 10 - Stockholders' Equity	'
	NOTE 10 - STOCKHOLDERS’ EQUITY
	Preferred Stock
	Our Amended and Restated Articles of Incorporation allow us to issue up to 10,000,000 shares of preferred stock without further stockholder approval and upon such terms and conditions, and having such rights, preferences, privileges, and restrictions as the Board of Directors may determine.  No preferred shares are currently issued and outstanding.
	Common Stock Issuances
	2013 Unit Offerings
	On January 25, 2013 we completed a private placement to accredited investors of 105,000 restricted shares of our common stock, at a purchase price of $1.00 per share, for gross proceeds of $105,000.  As part of the private placement, the investors were issued three-year warrants to purchase 105,000 shares of our common stock, at an exercise price of $1.50 per share.
	The net proceeds were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The amount allocated to the fair value of the warrants was $52,363 and the balance of the proceeds of $52,637 was allocated to the common stock.
	The fair value of the warrants issued in our unit private placement was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 3 years, risk free interest rate – 0.42%, volatility – 346.4%, and an expected dividend rate of 0%.
	From April 9 to July 11, 2013 we raised gross proceeds of $871,000 in a unit private placement to accredited investors at a price of $1.50 per unit.  Each unit is comprised of one share of common stock and one three-year warrant to purchase common stock at an exercise price of $2.00 per share.  Included in the proceeds is $110,000 of principal and interest which was converted into the unit offering as described in Note 8.  Also included is $10,000 received from a member of our board of directors.  We issued an aggregate of 580,667 shares of common stock and warrants to purchase 580,667 shares of common stock at an exercise price of $2.00 per share.
	The net proceeds of $761,000 were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The amount allocated to the fair value of the warrants was $256,836 and the balance of the proceeds of $504,164 was allocated to the common stock.  The fair value of the warrants issued was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 3 years, risk free interest rate – 0.34% to 0.65%, volatility – 91.4% to 150.3%, and an expected dividend rate of 0%.
	From October 10 to December 31, 2013 we received gross proceeds of $650,000 from accredited investors at a price of $1.00 per unit and issued 650,000 shares of common stock and two-year warrants to purchase 650,000 shares of common stock at an exercise price of $1.25 per share.
	The net proceeds of $650,000 were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The amount allocated to the fair value of the warrants was $217,155 and the balance of the proceeds of $432,845 was allocated to the common stock.  The fair value of the warrants issued was computed using the Black Scholes Option Pricing model using the following assumptions – expected life – 2 years, risk free interest rate – 0.28% to 0.38%, volatility – 81.5% to 113.0%, and an expected dividend rate of 0%.
	2013 Issuances of common stock
	During the year ended December 31, 2013 we issued 685,667 shares of common stock in our unit offerings described above and 368,162 shares of common stock upon the conversion of three of the convertible bridge loans as described in Note 6.
	During the year ended December 31, 2013 we issued 48,842 shares of common stock with a fair value of $75,000 to SAM Advisors, LLC. The issuances were based on the closing market prices as of the date of issuance pursuant to our agreement to convert their $12,500 monthly consulting fee to stock at the closing market price on the last business day of each month. SAM Advisors, LLC is an entity controlled by William B. Smith, our chairman and chief executive officer.  Effective July 1, 2013 Mr. Smith receives this amount in cash.
	During the year ended December 31, 2013 we issued 6,143 shares of common stock with a fair value of $11,250 to Charles Hunt, a member of our board of directors. The issuances were based in the closing market prices as of the date of issuance pursuant to our agreement to convert $3,750 of his monthly consulting fee to stock at the closing market price on the last business day of each month.
	2012 Unit Offering
	From January 24 to November 21, 2012 we sold 474,632 units at a subscription price of $3.50 per unit for gross proceeds of $1,661,199 in our unit private placement.  Each unit consisted of one share of common stock and a three-year warrant to purchase one share of common stock at an exercise price of $3.75 per share.  A total of 474,632 shares of common stock and warrants to purchase 474,632 shares of common stock at an exercise price of $3.75 were issued.  Included in these amounts are 12,000 shares of our common stock and 12,000 warrants issued upon the conversion of $42,000 in accounts payable to a vendor and 55,267 shares of our common stock and 55,267 warrants issued upon the conversion of loans totaling $193,431 (including accrued interest and loan fees of $18,431).  Also included in these amounts is cash investment of $105,000 and $15,000 received from two of our board members.
	The net proceeds of $1,425,768 were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The allocated fair value of the warrants was $583,638 and the balance of the proceeds of $842,130 was allocated to the common stock.
	The fair value of the shares issued to the vendor upon conversion of $42,000 of accounts payable was $70,920 based on the closing market price of our common stock on the date of conversion.  The fair value of the warrant issued was $46,979. We recognized a loss on conversion of accounts payable based on the difference between the fair value of the common stock and warrants issued to the vendor in the amount of $75,599.
	The fair value of the warrants issued in our unit private placement was calculated using the Black-Scholes option valuation model with the following assumptions:
	Closing market price of common stock		$0.70 to $6.00
	Estimated volatility		81.0% to 307.9%
	Risk free interest rate		0.28% to 0.56%
	Expected dividend rate		-
	Expected life		3 years
	On October 10, 2012 the board of directors reset the exercise price of the $3.75 per share warrants to purchase 474,632 warrants issued from $3.75 per share to $2.00 per share. All other terms and conditions of the warrants remain unchanged. Included in the total are 50,682 warrants owned by two members of our board of directors.  As a result of this reduction in price, the original allocation of the net proceeds of $1,425,768 would have resulted in $629,619 being allocated to the warrants and the balance of the proceeds of $796,149 was allocated to the common stock.
	On January 25, 2013 we amended the terms of the 2012 Unit Offering, reducing the purchase price of the unit to $1.00 and reducing the exercise price of the warrant to $1.50 per share.  As a result of the amendment, the Company issued an additional 1,186,567 shares of common stock to those investors and increased the number of shares reserved for issuance upon the exercise of the warrants by 1,186,567. The issuance of the shares under the amendment was considered non-compensatory; therefore, there was no effect on the results of operations. The effect of the issuance was a reallocation of the original gross proceeds among additional paid-in capital accounts attributable to the shares and warrants, based on the relative fair values of the instruments delivered in total, including those issued under the amended terms. As a result of this reduction in price and change in the number of issued shares, the allocation of the net proceeds of $1,425,768 would have resulted in $587,989 being allocated to the warrants and the balance of the proceeds of $837,779 would have been allocated to the common stock.
	2012 Issuances of common stock
	On September 11, 2012 we issued 12,500 shares of common stock with a fair value of $30,625 based on the closing market price as of that date to a vendor for services.  We recognized this as marketing expense in the accompanying statement of operations for the year ended December 31, 2012.
	Effective July 24, 2012 we issued 59,000 shares of our restricted common stock valued at $142,780 based on the closing market price for our common stock of $2.42 per share pursuant to an agreement with a vendor for investor relations services.  Effective August 31, 2012, we terminated the contract pursuant to its terms and cancelled the issuance of 52,858 shares.  Accordingly, we recognized the fair value of the 6,142 shares of $14,864 as marketing expense in the accompanying statements of operations for the year ended December 31, 2012.
	From August 31, 2012 to December 31, 2012 we issued 56,208 shares of common stock with a fair value of $62,500 to SAM Advisors, LLC. The issuances were based in the closing market prices as of the date of issuance pursuant to our agreement to convert their $12,500 monthly consulting fee to stock at the closing market price on the last business day of each month. SAM Advisors, Inc. is an entity controlled by William B. Smith, our chairman and chief executive officer.
	On December 20, 2012, we completed a private placement to accredited investors of 525,000 restricted shares of our common stock, at a purchase price of $0.80 per share, for gross proceeds of $420,000.  As part of the private placement, the investors were issued three-year warrants to purchase 525,000 shares of our common stock, at an exercise price of $1.50 per share.
	The net proceeds of $400,000 were allocated based on the relative fair values of the common stock and the warrants on the dates of issuance.  The allocated fair value of the warrants was $127,787 and the balance of the proceeds of $272,213 was allocated to the common stock.  The fair value of the warrants issued in our unit private placement was calculated using the Black-Scholes option valuation model with the following assumptions:
	Closing market price of common stock		$0.70
	Estimated volatility		101.20%
	Risk free interest rate		0.39%
	Expected dividend rate		-
	Expected life		3 years
	In addition, on December 20, 2012, we entered into a settlement and release agreement with a vendor and issued 250,000 shares of our restricted common stock and three-year warrants to purchase 250,000 shares of our common stock at an exercise price of $1.50 per share, in settlement of $250,000 of trade accounts payable.  The fair value of the shares issued was $175,000 based on the closing market price of our common stock on the date of conversion.  The fair value of the warrant issued was $82,151. We recognized a loss on conversion of accounts payable based on the difference between the fair value of the common stock and warrants issued to the vendor in the amount of $7,151.
	The fair value of the warrants issued in our unit private placement was calculated using the Black-Scholes option valuation model with the following assumptions:
	Closing market price of common stock		$0.70
	Estimated volatility		101.20%
	Risk free interest rate		0.39%
	Expected dividend rate		-
	Expected life		3 years
	Also on December 20, 2012, we entered into a settlement and release agreement with another vendor and issued 64,256 shares of our restricted common stock in settlement of $64,256 of trade accounts payable. The fair value of the shares issued was $44,979 based on the closing market price of our common stock on the date of conversion.  We recognized a gain on conversion of accounts payable based on the difference between the fair value of the common stock issued to the vendor in the amount of $19,277.
	Stock issuances
	A summary of activity related to grants of common stock under the 2007 Stock Incentive Plan as of December 31, 2013 is presented below.
		Number of   Shares		Grant Date Fair Value
	Outstanding, December 31, 2011	131,393		$4.60 to $22.80
	Granted	168,500		$3.26
	Forfeited	(2,795)		$8.00
	Outstanding, December 31, 2012	297,098		$2.24 to $22.80
	Granted	399,231		$1.20 to $1.61
	Forfeited	-		-
	Outstanding, December 31, 2013	696,329		$1.20 to $22.80
	Vested, December 31, 2013	524,070		$1.20 to $22.80
	A summary of the status of our nonvested stock grants as of December 31, 2013 and changes during the year ended December 31, 2013 is presented below.
	Nonvested Stock Grants	Number of   Shares		Weighted Average Grant Date Fair Value
	Nonvested at December 31, 2012	168,500		$                  8.00
	Granted	399,231		1.29
	Forfeited	-		-
Vested	(395,472)		9.20
Nonvested at December 31, 2013	172,259		$                  3.26
We made the following common stock awards for the year ended December 31, 2013 from the 2007 Stock Incentive Plan:
On February 20, 2013 we issued 80,000 shares of restricted stock from the 2007 Stock Incentive Plan to two board members and an officer for services vesting on the date of grant.  The shares had a fair value of $128,800 based on the closing market price of our common stock on that date of $1.61 per share.
On June 15, 2013 we issued 19,231 shares of restricted common stock to a consultant for services vesting in equal monthly installments through the one year anniversary date of service.  The shares had a fair value of $25,000 based on the closing market price of our common stock of $1.30 as of that date.
On August 26, 2013 we issued 300,000 shares of restricted common stock to our non-executive board members and an officer for services vesting ratably through June 1, 2014.  The shares had a fair value of $360,000 based in the closing market price of $1.20 as of that date.
We recognized a total of $544,889 and $311,336 of compensation expense related to restricted stock issuances as general and administrative and research and development expenses for the years ended December 31, 2013 and 2012, respectively.
At December 31, 2013 there are 172,259 shares of unvested restricted stock representing $207,587 of unrecognized compensation expense which we anticipate will be recognized in the first half of 2014.
We made the following common stock awards for the year ended December 31, 2012 from the 2007 Stock Incentive Plan:
On June 1, 2012 we granted a total of 148,500 shares of restricted common stock to the six non-executive board members for service on the board of directors.  The shares had a fair value of $504,900 based on the closing market price of $3.40 on the date of grant.  The shares vested on June 1, 2013.
On August 17, 2012 we granted 20,000 shares of restricted common stock to an officer for service.  The shares had a fair value of $44,800 based on the closing market price of $2.24 on the date of grant.  The shares vested on August 17, 2013.
On July 28, 2011, Bill K. Hamlin, then a member of our board of directors, was appointed to the positions of President and Chief Operating Officer of Vu1.  As part of his employment agreement, Mr. Hamlin agreed to convert $105,000 of his annual salary into 13,125 shares of our common stock at a conversion price of $8.00 per share, based on the closing market price of our common stock on the first day of his employment.  These shares vested in twelve equal monthly installments over the term of his employment agreement.  Mr. Hamlin resigned his position as President and Chief Operating Officer and director effective May 11, 2012.  We recognized a total of $37,869 of compensation expense relative to the 4,734 shares of common stock that vested during the year ended December 31, 2012. A total of 2,795 shares of unvested common stock were forfeited in 2012.
Option issuances
A summary of activity related to stock options under the 2007 Stock Incentive Plan as of December 31, 2013 is presented below.
	Number of   Shares		Exercise price range			Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding, December 31, 2011	591,181		$4.60 to $20.00		$	10.04	5.9	$           3,150
Granted	-		-		$	-
Exercised	-		-		$	-
Forfeited	(282,177)		$4.60 to $13.00		$	8.32
Outstanding, December 31, 2012	309,004		$4.60 to $20.00		$	11.62	6.0	$                 -
Granted	317,600		$1.28 to $1.70		$	1.65
Exercised	-		-		$	-
Forfeited	(31,516)		$7.80 to $20.00		$	12.54
Outstanding, December 31, 2013	595,088		$1.28 to $20.00		$	6.15	3.7	$                 -
Exercisable, December 31, 2013	511,755		$1.28 to $20.00		$	6.87	3.7	$                 -
The aggregate intrinsic value of the stock options fluctuates in relation to the market price of our common stock as reflected on the OTC Bulletin Board.
The range of exercise prices for options outstanding and options exercisable under the 2007 Stock Incentive Plan at December 31, 2013 are as follows:
Range of Exercise Prices		Weighted Average Remaining Contractual Life of Options Outstanding (in years)		Options Outstanding			Options Exercisable
				Number of   Shares		Weighted Average Exercise Price	Number of   Shares	Weighted Average Exercise Price
$1.28 to $1.70		4.9		317,600		$        1.65	234,267	$    1.64
$4.60		4		20,000		$        4.60	20,000	$    4.60
$7.60 to $8.60		5.2		140,407		$        8.17	140,407	$    8.17
$10.20 to $13.00		6.1		52,501		$      11.45	52,501	$  11.45
$20.00		4.7		64,580		$      20.00	64,580	$  20.00
A summary of the status of our nonvested options as of December 31, 2013 and changes during the year ended December 31, 2013 is presented below.
Nonvested Options	Number of   Shares Underlying Options		Weighted Average Grant Date Fair Value
Nonvested at December 31, 2012	2,828		$                  7.80
Granted	317,600		1.65
Forfeited or expired	(2,828)		7.80
Vested	(234,267)		1.65
Nonvested at December 31, 2013	83,333		$                  1.70
We made the following stock option awards for the year ended December 31, 2013 from the 2007 Stock Incentive Plan:
On February 20, 2013 we issued ten-year, fully vested options to purchase 42,600 shares of common stock from the 2007 Stock Incentive Plan at an exercise price of $1.61 per share to two board members and an officer for services.  The fair value of the options granted of $68,741 was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 10 years, risk free interest rate – 2.02%, volatility – 246.2%, and an expected dividend rate of 0%.
On March 11, 2013 we issued five-year options to purchase 250,000 shares of common stock at an exercise price of $1.70 per share to William B. Smith, our Chairman and Chief Executive Officer.  A total of 83,334 options vested immediately, with an additional 83,333 shares vesting on the six month and twelve month anniversary of the options.  In addition, certain performance based criteria provide for the potential acceleration of the vesting schedule.  The fair value of the options granted of $410,540 was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 5 years, risk free interest rate – 0.9%, volatility – 188.8%, and an expected dividend rate of 0%.
On November 11, 2013 we issued five-year, fully vested options to purchase 25,000 shares of common stock at an exercise price of $1.28 per share to a consultant. The fair value of the options granted of $22,055 was calculated using the Black-Scholes option valuation model with the following assumptions – expected life – 5 years, risk free interest rate – 1.47%, volatility – 88.5%, and an expected dividend rate of 0%.
We recognized compensation expense of $478,228 and $132,416 related to the vested portion of stock options based on their estimated grant date fair value as marketing expense, research and development expense or general and administrative expense based on the specific recipient of the award for the years ended December 31, 2013 and 2012, respectively.
During the year ended December 31, 2013 options to purchase 30,266 shares of common stock at a weighted average exercise price of $14.32 expired unexercised.
There were no grants of stock options from the 2007 Stock Incentive Plan for the year ended December 31, 2012.
We recognized compensation expense of $544,577 and $445,685 related to the vested portion of stock and stock options based on their estimated grant date fair value as research and development expense or general and administrative expense based on the specific recipient of the award for the years ended December 31, 2013 and 2012, respectively.
At December 31, 2013, there are 319,231 shares of unvested restricted stock issued in 2013 of which we anticipate $207,587 of unrecognized compensation expense will be recognized in 2014.   At December 31, 2013, we have unrecognized compensation expense related to stock options of $26,824 which will be recognized in 2014.
As of December 31, 2013, the 2007 Stock Incentive Plan has 1,223,299 shares available for future grants of stock or options.
Warrant Issuances and Exercises
We issue new shares when warrants are exercised.  There were no warrants exercised during the years ended December 31, 2013 and 2012.
2013 Warrants
As a result of the amendment of our 2012 Unit Offering as described above, the Company issued warrants to purchase an additional 1,186,567 shares of common stock at an exercise price of $1.50 per share to the investors in the offering.
On January 25, 2013 we issued three year warrants to purchase 105,000 shares of common stock at an exercise price of $1.50 per share in our unit offering described above.
From April 9 to July 11, 2013 we issued three year warrants to purchase 580,667 shares of common stock at an exercise price of $2.00 per share in our unit offering described above.
From October 10 to December 31, 2013 we issued two-year warrants to purchase 650,000 shares of common stock at an exercise price of $1.25 per share in our unit offering described above.
In February, 2013 we issued three year warrants to purchase 368,162 shares of our common stock at an exercise price of $1.50 per share and three year warrants to purchase 98,571 shares of our common stock at an exercise price of $11.00 per share to three investors upon the conversion of convertible bridge notes as described in Note 7.
During the year ended December 31, 2013 warrants to purchase a total of 230,858 shares of common stock with a weighted average exercise price of $15.31 expired unexercised.
2012 Warrants
During year ended December 31, 2012 we issued three year warrants at an exercise price of $3.75 per share to purchase 474,632 shares of common stock in our unit offering described above.  On October 10, 2012 the board of directors reset the exercise price of the $3.75 per share warrants to purchase 474,632 warrants issued from $3.75 per share to $2.00 per share. All other terms and conditions of the warrants remain unchanged. Included in the total are 50,682 warrants owned by two members of our board of directors.
Also during the year ended December 31, 2012 we issued three year warrants at an exercise price of $11.00 per share to purchase 57,500 shares of common stock to three investors upon the conversion of a convertible bridge notes as described in Note 7.
On December 20, 2012, we issued three-year warrants to purchase 525,000 shares of our common stock at an exercise price of $1.50 per share in conjunction with a private placement as of that date as described above.
In addition, on December 20, 2012, we issued three-year warrants to purchase 250,000 shares of our common stock at an exercise price of $1.50 per share, in settlement of $250,000 of trade accounts payable as described above.
On January 24, 2012, the exercise price of the warrants to purchase 262,750 shares of common stock issued in conjunction with our February 9, 2011 private placement was reduced from $11.00 per share to $9.00 per share as a result of the issuance of the common stock and warrants in our unit private placement describe above.
During the year ended December 31, 2012 warrants to purchase a total of 214,975 shares of common stock with a weighted average exercise price of $15.55 expired unexercised.
A summary of activity related to our warrants as of December 31, 2013 is presented below.
	Number of   Shares		Exercise price range			Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (Years)
Outstanding, December 31, 2011	921,963		$7.60 to $20.00		$	13.60	2.7
Granted	1,307,132		$1.50 to $11.00		$	2.10
Exercised	-		-		$	-
Forfeited	(214,975)		$15.00 to $20.00		$	15.55
Outstanding, December 31, 2012	2,014,120		$1.50 to $20.00		$	5.67	2.6
Granted	2,988,966		$1.25 to $11.00		$	1.86	1.8
Exercised	-		-
Forfeited	(230,858)		$7.60 to $20.00		$	15.31
Outstanding, December 31, 2013	4,772,228		$1.25 to $13.00		$	2.76	1.8
Exercisable, December 31, 2013	4,772,228		$1.25 to $13.00		$	2.76	1.8
The following table summarizes our outstanding warrants as of December 31, 2013:
				Weighted-Average
Exercise		Warrants		Remaining Contractual		Number
Price		Outstanding		Life (Years)		Exercisable
$1.25		650,000		1.9		650,000
$1.50		2,909,360		1.6		2,909,360
$2.00		580,667		2.5		580,667
$9.00		262,750		2.1		262,750
$11.00		156,071		1.9		156,071
$13.00		213,380		2.5		213,380
		4,772,228		1.8		4,772,228

Note_11_Income_Taxes

Note 11 - Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 11 - Income Taxes	'
	NOTE 11 - INCOME TAXES
	The net deferred tax asset is comprised of the following:
		December 31,
		2013	2012
	Net operating loss carryforwards	$          19,683,962	$           18,986,174
	Share-based compensation	1,404,983	1,792,487
	Valuation allowance	(21,088,945)	(20,778,661)
	Deferred income tax asset	$                          -	$                           -
	The provision for income taxes differs from the amount that would result from applying the federal statutory rate for the years ended December 31, 2013 and 2012 as follows:
		For the Years Ended December 31,
		2013	2012
	Net loss	$             5,019,977	$             3,825,448
	Tax at federal statutory rate (34%)	$          (1,706,792)	$          (1,300,652)
	Permanent differences	631,820	265,129
	Expiration of options and warrants	764,688	-
	Change in valuation allowance	310,284	1,035,523
	Provision for Income Taxes	$                          -	$                          -
	As of December 31, 2013, we had net operating loss carryforwards for U.S. federal income tax reporting purposes which if unused, will expire in the following years:
		US
	Year	Amount
	2018	$     27,080,269
	2019	1,745,867
	2020	6,137,725
	2021	5,251,175
	2022	1,751,322
	2023	78,281
	2024	413,886
	2025	508,429
	2026	465,173
	2027	760,272
	2028	2,494,690
	2029	2,121,595
	2030	1,688,397
	2031	2,433,302
	2032	2,911,306
	2033	2,052,317
		$     57,894,006
	The utilization of U.S. net operating loss carryforwards may be limited due to the ownership change under the provisions of Internal Revenue Code Section 382. The fiscal years 2010 to 2013 remain open to examination to U.S. Federal authorities and other jurisdictions in the U.S. where we operate.

Note_13_Sendio_Sro_Insolvency

Note 13 - Sendio, Sro Insolvency	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 13 - Sendio, Sro Insolvency	'
	NOTE 13 – SENDIO, SRO INSOLVENCY
	On February 13, 2012, Sendio filed a petition of insolvency with the Regional Court in Olomouc, Czech Republic.  In March, 2012 the court determined that Sendio was insolvent, and control of the legal entity passed to a court appointed trustee. The trustee is overseeing the orderly sale of the assets and using any proceeds to satisfy the liabilities of Sendio.  Included in the balance sheets are the following liabilities of Sendio that are subject to the insolvency proceedings:
		December 31,
		2013	2012
	Current liabilities:
	Accounts payable	$189,089	$189,089
	Accrued payroll	357,052	357,052
	Capital lease obligation, current portion	9,313	9,313
	Total liabilities of Sendio	$555,454	$555,454
	Our lease for the Sendio premises was terminated effective March 15, 2012 and our obligation to acquire the Sendio building was terminated on February 8, 2012.

Note_14_Subsequent_Events

Note 14 - Subsequent Events	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 14 - Subsequent Events	'
	NOTE 14 – SUBSEQUENT EVENTS
	On January 28, 2014 we entered into a lease agreement for approximately 4,600 square feet of office and light industrial space located in Berkeley, California in the United States.  We utilize the facility for our research and development activities and as our corporate headquarters.
	The lease term is for two years effective from February 1, 2014 and terminates on January 31, 2016. Our lease obligations are $55,000, $60,000 and $5,000 for the years ended December 31, 2014, 2015 and 2016, respectively.  The Company is also responsible for certain insurance, utilities, maintenance and other costs as described in the lease.
	Through March 27, 2014 we received gross proceeds of $150,000 from accredited investors at a price of $1.00 per unit and issued 150,000 shares of common stock and two-year warrants to purchase 150,000 shares of common stock at an exercise price of $1.25 per share.
	On February 11, 2014 we issued stock options to purchase 13,158 shares of common stock to a consultant at an exercise price of $1.14 per share based on the closing market price of our common stock as of that date.

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of Vu1 and all of its wholly-owned and controlled subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Note_2_Summary_of_Significant_2

Note 2 - Summary of Significant Accounting Policies: Translating Financial Statements (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Translating Financial Statements	'
	Translating Financial Statements
	The functional currency of Sendio was the Czech Koruna (CZK).  The accounts of Sendio contained in the accompanying consolidated balance sheets as of December 31, 2013 and 2012 have been translated into United States dollars at the exchange rate prevailing as of those dates. Translation adjustments were included in “Accumulated Other Comprehensive Income,” a separate component of stockholders’ equity. During the year ended December 31, 2012 we recognized the balance of Accumulated Other Comprehensive Income of $149,146 as a gain on liquidation of foreign subsidiary in the accompanying statement of operations for the year ended December 31, 2012 as we no longer have an ongoing investment in a foreign subsidiary.

Note_2_Summary_of_Significant_3

Note 2 - Summary of Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note_2_Summary_of_Significant_4

Note 2 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of the statements of cash flows, we consider all investments purchased with original maturities of three months or less to be cash equivalents. At December 31, 2013 we have no cash in excess of federal insurance limits.

Note_2_Summary_of_Significant_5

Note 2 - Summary of Significant Accounting Policies: Equipment (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Equipment	'
	Equipment
	Equipment is comprised of equipment used in the testing and development of the manufacturing process for our lighting products and is stated at cost. We provide for depreciation using the straight-line method over the estimated useful lives of three to five years. Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized. Gains or losses on the sale of equipment are reflected in the statements of operations.

Note_2_Summary_of_Significant_6

Note 2 - Summary of Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Income Taxes	'
	Income Taxes
	We recognize the amount of income taxes payable or refundable for the current year and recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement amounts of certain assets and liabilities and their respective tax bases. Deferred tax assets and deferred tax liabilities are measured using enacted tax rates expected to apply to taxable income in the years those temporary differences are expected to be recovered or settled. A valuation allowance is required when it is less likely than not that we will be able to realize all or a portion of our deferred tax assets.
	FASB ASC 740-10-25 clarifies the accounting for uncertain tax positions and requires that an entity recognizes in the consolidated financial statements the impact of a tax position, if that position is more likely than not of being sustained upon examination, based on the technical merits of the position.  Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits, if and when required, as part of income tax expense in the consolidated statements of operations.

Note_2_Summary_of_Significant_7

Note 2 - Summary of Significant Accounting Policies: Loan Costs (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Loan Costs	'
	Loan Costs
	Loan costs are amortized to interest expense using the straight line method, which approximates the effective interest method, over the life of the related loans.

Note_2_Summary_of_Significant_8

Note 2 - Summary of Significant Accounting Policies: Long-lived Assets (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Long-lived Assets	'
	Long-Lived Assets
	Long-lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount that the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  Management reviewed the assets at December 31, 2013 and determined there was no impairment.

Note_2_Summary_of_Significant_9

Note 2 - Summary of Significant Accounting Policies: Fair Value Measurements (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Fair Value Measurements	'
	Fair Value of Financial Instruments
	Financial instruments consist of cash, payables and accrued liabilities, loans payable, bridge loans and convertible debentures. The fair value of our cash, receivables, payables and accrued liabilities and loans payable are carried at historical cost; their respective estimated fair values approximate their carrying values due to the short term nature of these items. It is not practical to determine the fair value of our convertible debentures due to the unique terms and embedded financial instruments.
	Derivative financial instruments, as defined in ASC 815 “Accounting for Derivative Financial Instruments and Hedging Activities” consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g., interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. We generally do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.
	Fair Value Measurements
	ASC 820 “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. Significant fair value measurements resulted from the application of ASC 815 to our convertible promissory note and warrant financing arrangements and ASC 718-10 for our share-based payment arrangements.

Recovered_Sheet1

Note 2 - Summary of Significant Accounting Policies: Non-controlling Interest (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Non-controlling Interest	'
	Non-Controlling Interest
	Non-controlling interest represents the equity of the 33.3%

Recovered_Sheet2

Note 2 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Revenue Recognition	'
	Revenue Recognition
	Revenues are recognized when (a) persuasive evidence of an arrangement exists, (b) delivery has occurred and no significant obligations remain, (c) the fee is fixed or determinable and (d) collection is determined to be probable.

Recovered_Sheet3

Note 2 - Summary of Significant Accounting Policies: Research and Development Costs (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Research and Development Costs	'
	Research and Development Costs
	For financial reporting purposes, all costs of research and development activities performed internally or on a contract basis are expensed as incurred. For the years ended December 31, 2013 and 2012, research and development expenses were comprised primarily of technical consulting expenses, salaries and related benefits and overheads, travel, rent and operational costs related to the development of the production line.

Recovered_Sheet4

Note 2 - Summary of Significant Accounting Policies: Share-based Payments (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Share-based Payments	'
	Share-Based Payments
	We account for share-based compensation expense to reflect the fair value of share-based awards measured at the grant date.  This expense is recognized over the requisite service period and is adjusted each period for anticipated forfeitures. We estimate the fair value of each share-based award on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model incorporates assumptions as to stock price volatility, the expected life of options, a risk-free interest rate and dividend yield. On October 26, 2007 our Board of Directors approved the Vu1 Corporation 2007 Stock Incentive Plan (the “Stock Incentive Plan”).  A total of 500,000 shares of our common stock were authorized for issuance under the Stock Incentive Plan.  The Stock Incentive Plan was approved by our stockholders on May 22, 2008. On March 14, 2011, our Board of Directors increased the number of shares of our common stock that we are authorized to issue under our Stock Incentive Plan from 500,000 shares to 1,000,000 shares.  A majority of our stockholders approved the amendment to the Stock Incentive Plan on October 10, 2011. On August 26, 2013 the board of directors increased the number of shares authorized for issuance under the 2007 Stock Incentive Plan by 1,500,000 shares to a total of 2,500,000 shares. See Note 10.

Recovered_Sheet5

Note 2 - Summary of Significant Accounting Policies: Comprehensive Income (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Comprehensive Income	'
	Comprehensive Income
	Comprehensive income includes all changes in equity (net assets) during a period from non-owner sources. Other comprehensive income presented in the accompanying consolidated financial statements consists of foreign currency translation adjustments and a reclassification on disposal of foreign subsidiary.

Recovered_Sheet6

Note 2 - Summary of Significant Accounting Policies: Loss Per Share (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Loss Per Share	'
	Loss Per Share
	We calculate basic loss per share by dividing loss available to common stockholders by the weighted-average number of shares of common stock outstanding, excluding unvested stock. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common shares, including unvested stock, had been issued and if the additional common shares were dilutive.
	The following potentially dilutive common shares are excluded from the computation of diluted net loss per share for all periods presented because the effect is anti-dilutive due to our net losses:
		Year ended December 31,
		2013	2012
	Warrants	4,772,228	2,012,034
	Convertible debt	1,152,223	374,346
	Stock options	595,088	309,004
	Unvested stock	319,231	168,500
	Total potentially dilutive securities	6,838,770	2,863,884

Recovered_Sheet7

Note 2 - Summary of Significant Accounting Policies: Recently Announced Accounting Standards (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Recently Announced Accounting Standards	'
	Recently Announced Accounting Standards – In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). This update requires companies to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, unless certain conditions exist. ASU 2013-11 became effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted. The Company will adopt ASU 2013-11 when required in the first quarter of 2014. The Company does not believe the impact of ASU 2013-11 will have a material effect on the Company’s consolidated financial statements or on its financial condition.
	ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment, permits, but does not require, an entity to conduct an initial qualitative assessment to determine whether it is more likely than not that a non-goodwill indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test currently required (i.e., comparing the asset's fair value with its carrying amount). This new standard was adopted by the Company on September 30, 2012 and had no significant effect on the accompanying consolidated financial statements.
	ASU 2011-11, Disclosures about Offsetting Assets and Liabilities, requires disclosures about assets and liabilities that are offset or have the potential to be offset. This new guidance was effective for reporting periods beginning January 1, 2013, with retrospective application required. The adoption of this guidance did not have a material impact on the Company’s results of operations, financial position or disclosures.

Recovered_Sheet8

Note 2 - Summary of Significant Accounting Policies: Loss Per Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
		Year ended December 31,
		2013	2012
	Warrants	4,772,228	2,012,034
	Convertible debt	1,152,223	374,346
	Stock options	595,088	309,004
	Unvested stock	319,231	168,500
	Total potentially dilutive securities	6,838,770	2,863,884

Note_6_Convertible_Debentures_

Note 6 - Convertible Debentures: Schedule of Carrying Values of Convertible Debentures (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Carrying Values of Convertible Debentures	'
		31-Dec-13	31-Dec-12
	Debentures Due June 22, 2013, in default at December 31, 2013, interest at 18%	$                      1,352,975	$                   4,117,750
	Debentures Due June 23, 2014, interest at 10%	2,553,000	-
	Original issue discount	-	(155,443)
		3,905,975	3,962,307
	Beneficial conversion feature and warrant allocation	-	(415,811)
	Carrying value	$                      3,905,975	$                   3,546,496

Note_6_Convertible_Debentures_1

Note 6 - Convertible Debentures: Schedule Of Interest Expense Convertible Debentures (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule Of Interest Expense Convertible Debentures	'
		Year ended December 31,
		2013	2012
	Amortization of original issue discount	$                         155,443	$                      309,628
	Amortization of beneficial conversion feature and warrant allocation	415,811	722,956
	Amortization of loan costs	104,392	220,852
	Penalty interest payable in cash	144,121	-
	Stated interest payable in cash	259,168	-
		$                      1,078,935	$                    1,253,436

Note_8_Loans_Payable_Schedule_

Note 8 - Loans Payable: Schedule of maturities of debt (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of maturities of debt	'
		31-Dec-13
	2014	4,005,975
		$    4,005,975

Note_10_Stockholders_Equity_Fa

Note 10 - Stockholders' Equity: Fair Value, Option, Quantitative Disclosures (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Fair Value, Option, Quantitative Disclosures	'
	Closing market price of common stock	$0.70 to $6.00
	Estimated volatility	81.0% to 307.9%
	Risk free interest rate	0.28% to 0.56%
	Expected dividend rate	-
	Expected life	3 years

Note_10_Stockholders_Equity_Su

Note 10 - Stockholders' Equity: Summary of Activity Related To Grants of Common Stock Under The 2007 Stock Incentive Plan (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Summary of Activity Related To Grants of Common Stock Under The 2007 Stock Incentive Plan	'
		Number of   Shares	Grant Date Fair Value
	Outstanding, December 31, 2011	131,393	$4.60 to $22.80
	Granted	168,500	$3.26
	Forfeited	(2,795)	$8.00
	Outstanding, December 31, 2012	297,098	$2.24 to $22.80
	Granted	399,231	$1.20 to $1.61
	Forfeited	-	-
	Outstanding, December 31, 2013	696,329	$1.20 to $22.80
	Vested, December 31, 2013	524,070	$1.20 to $22.80

Note_10_Stockholders_Equity_Sc

Note 10 - Stockholders' Equity: Schedule of nonvested stock grants (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of nonvested stock grants	'
	Nonvested Stock Grants	Number of   Shares	Weighted Average Grant Date Fair Value
	Nonvested at December 31, 2012	168,500	$                  8.00
	Granted	399,231	1.29
	Forfeited	-	-
	Vested	(395,472)	9.20
	Nonvested at December 31, 2013	172,259	$                  3.26

Note_10_Stockholders_Equity_Sc1

Note 10 - Stockholders' Equity: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Stock Options, Activity	'
		Number of   Shares	Exercise price range		Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
	Outstanding, December 31, 2011	591,181	$4.60 to $20.00	$	10.04	5.9	$           3,150
	Granted	-	-	$	-
	Exercised	-	-	$	-
	Forfeited	(282,177)	$4.60 to $13.00	$	8.32
	Outstanding, December 31, 2012	309,004	$4.60 to $20.00	$	11.62	6.0	$                 -
	Granted	317,600	$1.28 to $1.70	$	1.65
	Exercised	-	-	$	-
	Forfeited	(31,516)	$7.80 to $20.00	$	12.54
	Outstanding, December 31, 2013	595,088	$1.28 to $20.00	$	6.15	3.7	$                 -
	Exercisable, December 31, 2013	511,755	$1.28 to $20.00	$	6.87	3.7	$                 -

Note_10_Stockholders_Equity_Sc2

Note 10 - Stockholders' Equity: Schedule of exercise prices for options outstanding and exercisable (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of exercise prices for options outstanding and exercisable	'
	Range of Exercise Prices	Weighted Average Remaining Contractual Life of Options Outstanding (in years)	Options Outstanding		Options Exercisable
			Number of   Shares	Weighted Average Exercise Price	Number of   Shares	Weighted Average Exercise Price
	$1.28 to $1.70	4.9	317,600	$        1.65	234,267	$    1.64
	$4.60	4	20,000	$        4.60	20,000	$    4.60
	$7.60 to $8.60	5.2	140,407	$        8.17	140,407	$    8.17
	$10.20 to $13.00	6.1	52,501	$      11.45	52,501	$  11.45
	$20.00	4.7	64,580	$      20.00	64,580	$  20.00

Note_10_Stockholders_Equity_Sc3

Note 10 - Stockholders' Equity: Schedule of nonvested options (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of nonvested options	'
	Nonvested Options	Number of   Shares Underlying Options	Weighted Average Grant Date Fair Value
	Nonvested at December 31, 2012	2,828	$                  7.80
	Granted	317,600	1.65
	Forfeited or expired	(2,828)	7.80
	Vested	(234,267)	1.65
	Nonvested at December 31, 2013	83,333	$                  1.70

Note_10_Stockholders_Equity_Sc4

Note 10 - Stockholders' Equity: Schedule of warrant activity (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of warrant activity	'
		Number of   Shares	Exercise price range		Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (Years)
	Outstanding, December 31, 2011	921,963	$7.60 to $20.00	$	13.60	2.7
	Granted	1,307,132	$1.50 to $11.00	$	2.10
	Exercised	-	-	$	-
	Forfeited	(214,975)	$15.00 to $20.00	$	15.55
	Outstanding, December 31, 2012	2,014,120	$1.50 to $20.00	$	5.67	2.6
	Granted	2,988,966	$1.25 to $11.00	$	1.86	1.8
	Exercised	-	-
	Forfeited	(230,858)	$7.60 to $20.00	$	15.31
	Outstanding, December 31, 2013	4,772,228	$1.25 to $13.00	$	2.76	1.8
	Exercisable, December 31, 2013	4,772,228	$1.25 to $13.00	$	2.76	1.8

Note_10_Stockholders_Equity_Sc5

Note 10 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Stockholders' Equity Note, Warrants or Rights	'
			Weighted-Average
	Exercise	Warrants	Remaining Contractual	Number
	Price	Outstanding	Life (Years)	Exercisable
	$1.25	650,000	1.9	650,000
	$1.50	2,909,360	1.6	2,909,360
	$2.00	580,667	2.5	580,667
	$9.00	262,750	2.1	262,750
	$11.00	156,071	1.9	156,071
	$13.00	213,380	2.5	213,380
		4,772,228	1.8	4,772,228

Note_11_Income_Taxes_Schedule_

Note 11 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'
		December 31,
		2013	2012
	Net operating loss carryforwards	$          19,683,962	$           18,986,174
	Share-based compensation	1,404,983	1,792,487
	Valuation allowance	(21,088,945)	(20,778,661)
	Deferred income tax asset	$                          -	$                           -

Note_11_Income_Taxes_Schedule_1

Note 11 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Effective Income Tax Rate Reconciliation	'
		For the Years Ended December 31,
		2013	2012
	Net loss	$             5,019,977	$             3,825,448
	Tax at federal statutory rate (34%)	$          (1,706,792)	$          (1,300,652)
	Permanent differences	631,820	265,129
	Expiration of options and warrants	764,688	-
	Change in valuation allowance	310,284	1,035,523
	Provision for Income Taxes	$                          -	$                          -

Note_11_Income_Taxes_Summary_o

Note 11 - Income Taxes: Summary of Tax Credit Carryforwards (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Summary of Tax Credit Carryforwards	'
		US
	Year	Amount
	2018	$     27,080,269
	2019	1,745,867
	2020	6,137,725
	2021	5,251,175
	2022	1,751,322
	2023	78,281
	2024	413,886
	2025	508,429
	2026	465,173
	2027	760,272
	2028	2,494,690
	2029	2,121,595
	2030	1,688,397
	2031	2,433,302
	2032	2,911,306
	2033	2,052,317
		$     57,894,006

Note_13_Sendio_Sro_Insolvency_

Note 13 - Sendio, Sro Insolvency: assets and liabilities of Sendio that are subject to the insolvency proceedings (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
assets and liabilities of Sendio that are subject to the insolvency proceedings	'
		December 31,
		2013	2012
	Current liabilities:
	Accounts payable	$189,089	$189,089
	Accrued payroll	357,052	357,052
	Capital lease obligation, current portion	9,313	9,313
	Total liabilities of Sendio	$555,454	$555,454

Note_1_Business_and_Organizati1

Note 1 - Business and Organization (Details)	12 Months Ended
	Dec. 31, 2013
Details	'
Cumulative Percentage of Ownership	66.67%

Recovered_Sheet9

Note 2 - Summary of Significant Accounting Policies: Translating Financial Statements (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Reclassification adjustment on disposal of foreign subsidiary	$149,146	$149,196

Recovered_Sheet10

Note 2 - Summary of Significant Accounting Policies: Non-controlling Interest (Details)	Dec. 31, 2013
Details	'
Non-controlling Interest, Telisar Corporation	33.30%

Recovered_Sheet11

Note 2 - Summary of Significant Accounting Policies: Loss Per Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,838,770	2,863,884
Warrant	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,772,228	2,012,034
Convertible Debt Securities	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,152,223	374,346
Stock Options	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	595,088	309,004
Unvested Stock	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	319,231	168,500

Note_3_Going_Concern_Matters_D

Note 3 - Going Concern Matters (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Net loss	$5,019,977	$3,825,448
Net cash flows from operating activities	1,716,606	1,568,781
Accumulated deficit	$88,426,616	$83,406,639

Note_4_Related_Party_Transacti1

Note 4 - Related Party Transactions (Details) (USD $)	4 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
		Sam Advisors	Sam Advisors	CharlesHuntMember	DuncanTroyMember
Issued Shares	56,208	48,842	'	6,143	'
Common Stock Fair Value	'	$75,000	'	$11,250	'
Converted Consulting Fees	'	12,500	'	3,750	'
Costs and Expenses, Related Party	'	'	$125,000	'	$22,382

Note_5_Commitments_and_Conting1

Note 5 - Commitments and Contingencies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 18, 2012	Jul. 11, 2011
Details	'	'	'	'
Operating Lease Monthly Payments	'	'	$2,035	$1,445
Rent Expense	$24,647	$9,859	'	'

Note_6_Convertible_Debentures_2

Note 6 - Convertible Debentures (Details) (USD $)	Oct. 10, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 22, 2011
		ConvertibleDebenturesMember	ConvertibleDebenturesMember	ConvertibleDebenturesMember
Proceeds from issuance of convertible notes payable and warrants	'	'	$3,500,000	'
Debenture Issue Price Percentage	'	85.00%	'	'
Conversion Price per Share	'	'	'	$11
Limit on Beneficial Ownership as a Percentage of Outstanding Shares	'	'	'	4.99%
Debt Securities Default Condition Monetary Limit	'	$150,000	'	'
Assets Disposal Percentage	'	50.00%	'	'
Warrants Issued in Conjunction with Convertible Debentures	'	187,175	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	$3.75	'	'	$13

Note_6_Convertible_Debentures_3

Note 6 - Convertible Debentures: Schedule of Carrying Values of Convertible Debentures (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
Original issue discount	'		($155,443)
Issue price	3,905,975		3,962,307
Beneficial conversion feature and warrant allocation	'		-415,811
Carrying value	3,905,975		3,546,496
DebenturesDueJune222013Member	'		'
Face amount	1,352,975	[1]	4,117,750	[1]
DebenturesDueJune232014Member	'		'
Face amount	$2,553,000	[2]	'
[1]	Interest at 18%
[2]	Interest at 10%

Note_6_Convertible_Debentures_4

Note 6 - Convertible Debentures: Schedule Of Interest Expense Convertible Debentures (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Amortization of original issue discount	$155,443	$309,628
Amortization of beneficial conversion feature and warrant allocation	415,811	722,956
Amortization of loan costs	104,392	220,852
Penalty Interest Payable in Cash	144,121	'
Stated Interest Payable in Cash	259,168	'
Interest Expense Related to Convertible Debentures	$1,078,935	$1,253,436

Note_7_Convertible_Bridge_Loan1

Note 7 - Convertible Bridge Loans (Details) (USD $)	Oct. 10, 2012	Dec. 31, 2013	Dec. 31, 2012	Nov. 21, 2012	Dec. 31, 2013	Dec. 31, 2012	Jan. 31, 2013	Jun. 22, 2011
		Mark W Weber	Mark W Weber	ConvertibleBridgeLoans1Member	ConvertibleBridgeLoans1Member	ConvertibleBridgeLoans1Member	ConvertibleBridgeLoans1Member	ConvertibleBridgeLoans1Member
Proceeds from issuance of bridge notes	'	$50,000	'	'	$475,000	'	'	'
Debt Instrument, Interest Rate, Effective Percentage	'	'	'	'	12.00%	'	'	'
Debt Instrument, Convertible, Interest Expense	'	'	'	'	7,027	54,103	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	$3.75	'	'	'	$11	'	$1.50	$3.75
Debt Conversion, Converted Instrument, Amount	'	'	57,385	193,431	368,162	193,431	'	'
Accrued Interest and Loan Fees Included in Conversion	'	'	7,385	18,431	68,162	18,431	'	'
Debt Conversion Converted Instrument Units Issued One	'	'	16,396	55,267	368,162	55,267	'	'
Debt Conversion Converted Instrument Units Issued Two	'	'	16,429	'	98,571	57,500	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights, Two	'	'	$11	'	$11	$11	'	'
Fair Value of Common Stock	'	'	'	'	662,690	230,540	'	'
Fair Value of Three Year Warrants, One	'	'	'	'	633,121	171,023	'	'
Expected life (years)	'	'	'	'3 years	'3 years	'3 years	'	'
Risk-free interest rate	'	'	'	'	0.82%	0.31%	'	'
Estimated volatility	'	'	'	'	227.10%	103.60%	'	'
Expected Dividend Rate	'	'	'	'	0.00%	0.00%	'	'
Debt Conversion, Converted Instrument, Shares Issued	'	'	16,396	55,267	'	55,267	'	'
Market Price at Conversion, Lower	'	'	'	'	'	$2.11	'	'
Market Price at Conversion, Upper	'	'	'	'	'	$5.75	'	'
Fair Value of Three Year Warrants, Two	'	'	'	'	'	145,029	'	'
Loss on conversion of debt	'	'	'	'	'	$353,161	'	'
Risk-free interest rate, Upper Range	'	'	'	'	'	0.82%	'	'
Estimated volatility, Upper Range	'	'	'	'	'	198.40%	'	'

Note_8_Loans_Payable_Schedule_1

Note 8 - Loans Payable: Schedule of maturities of debt (Details) (USD $)	Dec. 31, 2013
Details	'
2014	$4,005,975

Note_9_Derivative_Financial_In1

Note 9 - Derivative Financial Instruments (Details) (DerivativeWarrantLiability1Member, USD $)	12 Months Ended
	Dec. 31, 2012	Jan. 24, 2012	Feb. 09, 2011
DerivativeWarrantLiability1Member	'	'	'
Warrants Issued Number Of Securities Callable By Warrants	'	'	262,750
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Before Amendment	'	'	$12
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights After Amendment	'	'	$9
Debt Instrument, Convertible, Conversion Price	'	$9	'
Fair Value Difference	$46,444	'	'
Derivative Gain	$639,227	'	'

Note_10_Stockholders_Equity_Pr

Note 10 - Stockholders' Equity: Preferred Stock (Details)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Preferred stock shares authorized	10,000,000	10,000,000

Note_10_Stockholders_Equity_20

Note 10 - Stockholders' Equity: 2013 Unit Offering (Details) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2013	Mar. 31, 2013	Mar. 31, 2013
				N2013UnitOfferingMember	CommonStockAndWarrantsMember
Restricted Shares To Accredited Investors	'	'	'	105,000	'
Purchase Price	'	'	'	$1	'
Proceeds From Restricted Shares To Accredited Investors	'	'	'	$105,000	'
Issuance Of Three Year Warrants	'	'	'	105,000	'
Warrant Exercise Price	'	'	'	$1.50	'
Proceeds Allocated To Warrants	'	'	'	52,363	'
Proceeds Allocated To Common Stock	'	'	'	52,637	'
Expected life (years)	'	'	'	'3 years	'3 years
Risk-free interest rate	'	'	'	0.42%	0.34%
Estimated volatility	'	'	'	346.40%	91.40%
Expected Dividend Rate	'	'	'	0.00%	0.00%
Proceeds raised from accredited investors	650,000	871,000	'	'	'
Converted Loan Conversion Price	$1	$1.50	'	'	'
Converted Loan Amount	'	'	110,000	'	'
Proceeds from board of directors	'	'	10,000	'	'
Aggregate shares issued	'	'	580,667	'	'
Exercise Price	'	'	$2	'	'
Net proceeds raised	650,000	761,000	'	'	'
Fair Value Allocated to warrants	'	217,155	256,836	'	'
Fair Value Allocated to common stock	$432,845	$504,164	'	'	'

Note_10_Stockholders_Equity_201

Note 10 - Stockholders' Equity: 2013 Issuances of common stock (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Shares Issued in Unit Offering	685,667
Sam Advisors	'
Issuance Of Common Shares	48,842
Common Stock Fair Value	75,000
Converted Consulting Fees	12,500
CharlesHuntMember	'
Issuance Of Common Shares	6,143
Common Stock Fair Value	11,250
Converted Consulting Fees	3,750
ConvertibleBridgeLoans1Member	'
Bridge Loan Converted Into Shares Of Restricted Common Stock	368,162

Note_10_Stockholders_Equity_202

Note 10 - Stockholders' Equity: 2012 Unit Offering (Details) (USD $)

10 Months Ended

12 Months Ended

10 Months Ended

12 Months Ended

10 Months Ended

12 Months Ended

Nov. 21, 2012

Dec. 31, 2013

Jan. 25, 2013

Oct. 10, 2012

Nov. 21, 2012

Nov. 21, 2012

Nov. 21, 2012

Nov. 21, 2012

Nov. 21, 2012

Nov. 21, 2012

Dec. 31, 2013

Nov. 21, 2012

Dec. 31, 2013

Dec. 31, 2012

Jan. 31, 2013

Jun. 22, 2011

Minimum

Maximum

Director One

Director Two

AccountsPayableConversionMember

CommonStock1Member

CommonStock1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

PrivatePlacementUnitsSold

474,632

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unit Subscription Price

$3.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Private Placement

$1,661,199

'

'

'

'

'

$105,000

$15,000

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

$3.75

'

'

'

'

'

'

$3.75

'

$11

'

$1.50

$3.75

Shares Issued in Unit Offering

'

685,667

'

'

'

'

'

'

'

474,632

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Shares Issued

'

'

'

'

'

'

'

'

12,000

'

'

55,267

'

55,267

'

'

Debt Conversion, Converted Instrument, Amount

'

'

'

'

'

'

'

'

42,000

'

'

193,431

368,162

193,431

'

'

Debt Conversion Converted Instrument Units Issued One

'

'

'

'

'

'

'

'

'

'

'

55,267

368,162

55,267

'

'

Accrued Interest and Loan Fees Included in Conversion

'

'

'

'

'

'

'

'

'

'

'

18,431

68,162

18,431

'

'

Net Proceeds Of Warrants And Common Stock

'

'

'

'

'

'

'

'

'

'

1,425,768

'

'

'

'

'

Fair Value of Warrants

'

'

'

'

'

'

'

'

'

583,638

'

'

'

'

'

'

Balance of Proceeds Allocated to Common Stock

'

'

'

'

'

'

'

'

'

842,130

'

'

'

'

'

'

Fair value of the shares issued to the vendor

'

70,920

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of the warrant issued

'

46,979

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss on conversion of accounts payable

'

$75,599

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing Market Price Of Common Stock

'

'

'

'

$0.70

$6

'

'

'

'

'

'

'

'

'

'

Estimated volatility

'

'

'

'

81.00%

307.90%

'

'

'

'

'

'

227.10%

103.60%

'

'

Risk-free interest rate

'

'

'

'

0.28%

0.56%

'

'

'

'

'

'

0.82%

0.31%

'

'

Expected life (years)

'

'

'

'

'

'

'

'

'

'

'

'3 years

'3 years

'3 years

'

'

Aggregate Warrants Outstanding

'

'

'

474,632

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price of Warrants Subsequent to Reset

'

'

$1.50

$2

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Outstanding Owned by Related Parties

'

'

'

50,682

'

'

'

'

'

'

'

'

'

'

'

'

PurchasePriceOfUnitSubsequentToReset

'

'

$1

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_10_Stockholders_Equity_De

Note 10 - Stockholders' Equity (Details) (USD $)

4 Months Ended

9 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2012

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 20, 2012

Oct. 10, 2012

Aug. 31, 2012

Jul. 24, 2012

Jul. 28, 2011

Aug. 17, 2012

Jun. 01, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 31, 2013

Jun. 22, 2011

Dec. 20, 2012

Dec. 20, 2012

Stock and Options 2007 Stock Incentive Plan

Stock and Options 2007 Stock Incentive Plan

CommonStock1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

ConvertibleBridgeLoans1Member

CommonStock2Member

CommonStock3Member

Issued Shares

56,208

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value of Shares Issued

$62,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing Market Price

'

'

'

'

'

'

'

$2.42

'

'

'

'

'

'

'

'

'

'

Shares Cancelled

'

'

'

'

'

'

52,858

'

'

'

'

'

'

'

'

'

'

'

Shares Remaining

'

'

'

'

'

'

6,142

'

'

'

'

'

'

'

'

'

'

'

Fair Value of Shares Recognized as Marketing Expense

'

14,864

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Monthly Consulting Fee

12,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Private placement to accredited investors

'

'

'

'

525,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Private placement to accredited investors per share

'

'

'

'

$0.80

'

'

'

'

'

'

'

'

'

'

'

'

'

Private placement to accredited investors proceeds

'

'

'

'

420,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Private placement to accredited investors warrants

'

'

'

'

525,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Private placement to accredited investors warrants per share

'

'

'

'

$1.50

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Shares Granted

'

'

'

'

'

'

'

'

'

20,000

148,500

'

'

'

'

'

'

'

Restricted Shares Granted, Fair Value

'

'

'

'

'

'

'

'

'

44,800

504,900

'

'

'

'

'

'

'

Closing Market Price, Restricted Shares Fair Value

'

'

'

'

'

'

'

'

'

$2.24

$3.40

'

'

'

'

'

'

'

Salary Converted to Shares

'

'

'

'

'

'

'

'

105,000

'

'

'

'

'

'

'

'

'

Shares Issued upon Conversion of Annual Salary

'

'

'

'

'

'

'

'

13,125

'

'

'

'

'

'

'

'

'

Conversion Price Shares Issued upon Conversion of Annual Salary

'

'

'

'

'

'

'

'

$8

'

'

'

'

'

'

'

'

'

Compensation Expense, President and COO

'

'

$37,869

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Vested, President and COO

'

'

4,734

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares Forfeited, President and COO

'

'

'

2,795

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued in Unit Offering

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

525,000

250,000

Class of Warrant or Right, Exercise Price of Warrants or Rights, Two

'

'

'

'

'

'

'

'

'

'

'

'

$11

$11

'

'

'

'

Debt Conversion Converted Instrument Units Issued Two

'

'

'

'

'

'

'

'

'

'

'

'

98,571

57,500

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

'

'

$3.75

'

'

'

'

'

$3.75

$11

'

$1.50

$3.75

$1.50

$1.50

Warrants Expired

'

'

'

214,975

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price of Warrants Expired

'

'

'

$15.55

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_10_Stockholders_Equity_Sc6

Note 10 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	Dec. 31, 2013
Warrants Outstanding	4,772,228
Weighted - Average Remaining Contractual Life (Years)	1.8
Warrants Exercisable	4,772,228
Warrant One	'
Exercise Price, Warrants	1.25
Warrants Outstanding	650,000
Weighted - Average Remaining Contractual Life (Years)	1.9
Warrants Exercisable	650,000
Warrant Two	'
Exercise Price, Warrants	1.5
Warrants Outstanding	2,909,360
Weighted - Average Remaining Contractual Life (Years)	1.6
Warrants Exercisable	2,909,360
Warrant Three	'
Exercise Price, Warrants	2
Warrants Outstanding	580,667
Weighted - Average Remaining Contractual Life (Years)	2.5
Warrants Exercisable	580,667
Warrant Four	'
Exercise Price, Warrants	9
Warrants Outstanding	262,750
Weighted - Average Remaining Contractual Life (Years)	2.1
Warrants Exercisable	262,750
Warrant Five	'
Exercise Price, Warrants	11
Warrants Outstanding	156,071
Weighted - Average Remaining Contractual Life (Years)	1.9
Warrants Exercisable	156,071
Warrant Six	'
Exercise Price, Warrants	13
Warrants Outstanding	213,380
Weighted - Average Remaining Contractual Life (Years)	2.5
Warrants Exercisable	213,380

Note_11_Income_Taxes_Schedule_2

Note 11 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Operating Loss Carryforwards	$19,683,962	$18,986,174
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost	1,404,983	1,792,487
Operating Loss Carryforwards, Valuation Allowance	($21,088,945)	($20,778,661)

Note_11_Income_Taxes_Schedule_3

Note 11 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Loss before provision for income taxes	$5,019,977	$3,825,448
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	-1,706,792	-1,300,652
Permanent differences	631,820	265,129
Valuation Allowance, Deferred Tax Asset, Change in Amount	310,284	1,035,523
Provision for income taxes	'	'

Note_13_Sendio_Sro_Insolvency_1

Note 13 - Sendio, Sro Insolvency: assets and liabilities of Sendio that are subject to the insolvency proceedings (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accrued payroll	$192,725	$192,725
Total current liabilities	6,227,053	5,712,367
Sendio	'	'
Accounts Payable, Current	189,089	189,089
Accrued payroll	357,052	357,052
Capital lease obligation, current portion	9,313	9,313
Total current liabilities	$555,454	$555,454

Note_14_Subsequent_Events_Deta

Note 14 - Subsequent Events (Details) (USD $)	1 Months Ended	3 Months Ended
	Feb. 28, 2014	Mar. 27, 2014	Dec. 31, 2013
Details	'	'	'
Operating Leases, Future Minimum Payments, Next Rolling Twelve Months	'	'	$55,000
Operating Leases, Future Minimum Payments, Due in Two Years	'	'	60,000
Operating Leases, Future Minimum Payments, Due in Three Years	'	'	5,000
Proceeds from Issuance of Common Stock	'	$150,000	'
Stock Issued During Period, Shares, Other	13,158	150,000	'
Issuance of Warrants for Cash	'	150,000	'